Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
39.83
+1.58 (4.13%)
At close: Dec 5, 2025, 4:00 PM EST
39.51
-0.32 (-0.80%)
After-hours: Dec 5, 2025, 7:36 PM EST
HRMY Employees
Harmony Biosciences Holdings had 268 employees as of December 31, 2024. The number of employees increased by 22 or 8.94% compared to the previous year.
Employees
268
Change (1Y)
22
Growth (1Y)
8.94%
Revenue / Employee
$3,081,881
Profits / Employee
$692,821
Market Cap
2.29B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HRMY News
- 4 days ago - Harmony Biosciences to Present New Open-Label Extension Data from Phase 3 ARGUS Trial at the 2025 American Epilepsy Society Annual Meeting - Business Wire
- 12 days ago - Harmony Biosciences Announces Positive Results From the Pivotal Bioequivalence Study for Pitolisant Gastro-Resistant Formulation - Business Wire
- 17 days ago - Harmony Biosciences Announces Initiation of First-In-Human Study With Potential Best-In-Class Orexin 2 Receptor Agonist (BP1.15205) for Central Disorders of Hypersomnolence - Business Wire
- 18 days ago - Harmony Biosciences to Participate in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Harmony Biosciences Holdings, Inc. (HRMY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M - Business Wire
- 6 weeks ago - Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance - Business Wire
- 7 weeks ago - 3 Biotech Stocks I Am Accumulating - Seeking Alpha